A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07288138 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Dysfunction-associated Steatohepatitis

Interventions

DRUG: Placebo
DRUG: ECC4703
DRUG: ECC0509
DRUG: ECC4703

Sponsor

Eccogene